BioSniper
ZH
Toggle language
Open menu
Phase 2 Readout
~quarter
Phase 2 Readout: fb102
December 31, 2026
Company
Forte Biosciences, Inc. (FBRX)
Drug
fb102
Indication
celiac
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
FBRX Overview
PDUFA Dates
Phase 3 Readouts
Phase 2 Readout: fb102 — FBRX Phase 2 Readout | BioSniper